Medical Research | Tissuepathology.com

Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications

Erica Goodpaster — Thu, 27 Aug 2026 13:04:38 +0000

Tempus’ multimodal foundation model offers diagnostic-grade precision for cancer detection and unlocks broader applications predicting biomarker status and patient prognosis CHICAGO, August 4, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced study results demonstrating that PRISM2, a multimodal slide-level pathology […]

The post Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications first appeared on Tissuepathology.com.

Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule

Erica Goodpaster — Tue, 21 Jul 2026 11:30:50 +0000

Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions. Optiscan Imaging (ASX: OIL) has begun Stage 2 of its first-in-human head and neck cancer imaging study at St John of God Murdoch Hospital in Perth ahead of schedule. The hospital’s Human Research Ethics […]

The post Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule first appeared on Tissuepathology.com.

Mayo Clinic study shows AI can help clinicians identify brain tumor risks

Erica Goodpaster — Thu, 25 Jun 2026 12:54:00 +0000

ROCHESTER, Minn. — Mayo Clinic researchers and collaborators have shown that an artificial intelligence (AI) tool can analyze routine pathology slides to help clinicians classify meningiomas, the most common primary brain tumor in adults, and better understand a patient’s risk of tumor recurrence. The study, published in The Lancet Digital Health, demonstrates that deep learning models can support the extraction of […]

The post Mayo Clinic study shows AI can help clinicians identify brain tumor risks first appeared on Tissuepathology.com.

ASCO: Now and Then

Dr. Keith J. Kaplan — Thu, 11 Jun 2026 18:00:28 +0000

In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in downtown Chicago was $1000/month. I wasshort over $300 a […]

The post ASCO: Now and Then first appeared on Tissuepathology.com.

Call for papers: Breast cancer biomarkers in diagnostic and translational pathology – Breast Cancer: Targets and Therapy

Erica Goodpaster — Wed, 20 May 2026 11:28:40 +0000

Taylor & Francis is pleased to invite you to submit your work to an upcoming Article Collection on “Breast cancer biomarkers in diagnostic and translational pathology” in the journal Breast Cancer: Targets and Therapy. This Article Collection will focus on investigating immunohistochemical and molecular biomarker testing in breast cancer, with particular emphasis on optimizing reproducibility and […]

The post Call for papers: Breast cancer biomarkers in diagnostic and translational pathology – Breast Cancer: Targets and Therapy first appeared on Tissuepathology.com.

American Center for Cancer Research: DNA methylation “fingerprints” identify primary sites in metastatic cancers

Erica Goodpaster — Tue, 21 Apr 2026 13:47:18 +0000

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22. CUP are metastatic malignancies in which the primary cancer site could not […]

The post American Center for Cancer Research: DNA methylation “fingerprints” identify primary sites in metastatic cancers first appeared on Tissuepathology.com.